The following are our general objectives in this trial:
1. Effect of vitamin D3 on discogenic pain
2. Effect of vitamin D3 on discogenic sensory deficits
3. Effect of posttreatment 25-hydroxy vitamin D3 level
on pain and sensory deficit severity
4. Determining a cut-off level of 25-hydroxy vitamin D3
that is efficient in improving pain and sensory
deficits
The following are our applicative objectives:
1. Proposing vitamin D3 as part of medical treatment
for LDH
2. Improving LDH patients’ quality of life
3. Decreasing the economic and health burden of LDH
Our ultimate goal in this study is to introduce a new
treatment strategy for the treatment of discogenic pain.